Feng Meng

703 citations
15 papers · 566 · h-index 9

Impact in

  • Hematology top 5%
    • Chronic Myeloid Leukemia Treatments
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Chronic Myeloid Leukemia Treatments 5
    • Cancer Immunotherapy and Biomarkers 3

Feng Meng

15 papers receiving 552 citations

Peers

Feng Meng
Comparison fields: 5 of 56
  • Hematology 192
  • Oncology 124
  • Geriatrics and Gerontology 18
  • Genetics 64
  • Molecular Medicine 12
Replace Daphné Dupéré-Richer with:
Daphné Dupéré-Richer United States
Valgarður Sigurðsson Sweden
Camino Bermejo‐Rodríguez United Kingdom
Masayuki Umeda United States
Michaela Schneider Germany
Aikaterini Semilietof Switzerland
Stacy Grieve Canada
Aarthi Jayanthan Canada
Kristina Drott Sweden
Yusuke Nakauchi United States
Feng Meng relative to Daphné Dupéré-Richer United States Daphné Dupéré-Richer's profile →
Citations per field
00.5×2×3×4×4.6×
Daphné Dupéré-Richer · 1×
Citations per year

Countries citing papers authored by Feng Meng

Since Specialization
Citations

This map shows the geographic impact of Feng Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Meng more than expected).

Fields of papers citing papers by Feng Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Meng. The network helps show where Feng Meng may publish in the future.

Co-authors

The 25 scholars most cited alongside Feng Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feng Meng Line = papers co-authored together Feng Meng links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 2008134
2 2019124
3 200890
4
Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms.
200356
5 200232
6 201130
7 200229
8 201528
9 202215
10 20179
11 20057
12 20235
13 20254
14 20082
15 20041

About Feng Meng

Feng Meng is a scholar working on Hematology, Oncology, Geriatrics and Gerontology, Pulmonary and Respiratory Medicine and Neurology, having authored 15 papers that have together received 566 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (2 papers), Neurofibromatosis and Schwannoma Cases (1 paper), RNA Interference and Gene Delivery (1 paper), Sirtuins and Resveratrol in Medicine (1 paper), Virus-based gene therapy research (1 paper) and Nuclear Receptors and Signaling (1 paper). The work is most often cited by research in Hematology (192 citations), Oncology (124 citations), Geriatrics and Gerontology (18 citations), Genetics (64 citations) and Molecular Medicine (12 citations). Feng Meng has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Ji Yuan Wu, Nicholas J. Donato, Moshe Talpaz, Zhenghong Peng, William G. Bornmann, Mourad Majidi, Jack A. Roth, Ismail Mustafa Meraz, Elizabeth J. Shpall and Ling-Yuan Kong. Their work appears in journals such as Blood, Communications Biology, Thrombosis and Haemostasis, Molecular Cancer Therapeutics and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact